Copyright
©The Author(s) 2024.
World J Methodol. Dec 20, 2024; 14(4): 95881
Published online Dec 20, 2024. doi: 10.5662/wjm.v14.i4.95881
Published online Dec 20, 2024. doi: 10.5662/wjm.v14.i4.95881
Category | Features | Follow-up periods |
No DR | No findings | 12 months |
Very mild NPDR | Microaneurysms only | Most of the patients in 12 months |
Mild NPDR | Any or all of: Microaneurysms, retinal hemorrhages, exudates, cotton wool spots | 6-12 months, depending on the severity of signs, stability, systemic factors, and patient’s personal circumstances |
Moderate NPDR | Severe retinal hemorrhages in 1-3 quadrants or mild IRMA; Significant venous beading in no more than one quadrant; Cotton wool spots | Approximately 6 months (PDR in up to 26%, high-risk PDR in up to 8% within a year) |
Severe NPDR | The 4-2-1 rule; Severe retinal hemorrhages in all four quadrants; Significant venous beading in ≥ 2 quadrants; Moderate IRMA in > 1 quadrant | 4 months (PDR in up to 50%, High-risk PDR in up to 15% within a year) |
Very severe NPDR | ≥ 2 of the criteria for severe | 2-3 months (high-risk PDR in up to 45% within a year) |
High-risk PDR | NVD > 1/3rd disc area; Any NVD with vitreous/Pre-retinal hemorrhage; NVE > 1/2 disc area with vitreous/pre-retinal hemorrhage | Laser photocoagulation Intravitreal Anti-VEGF agents Intravitreal Triamcinolone Pars Plana Vitrectomy; Lipid-lowering drugs |
Advanced diabetic eye disease | Pre-retinal (retro hyaloid) and/or intragel hemorrhage; Tractional retinal detachment Tractional retinoschisis Rubeosis Iridis (Iris Neovascularization) | Pars plana vitrectomy |
- Citation: Morya AK, Ramesh PV, Nishant P, Kaur K, Gurnani B, Heda A, Salodia S. Diabetic retinopathy: A review on its pathophysiology and novel treatment modalities. World J Methodol 2024; 14(4): 95881
- URL: https://www.wjgnet.com/2222-0682/full/v14/i4/95881.htm
- DOI: https://dx.doi.org/10.5662/wjm.v14.i4.95881